TY  - GEN
AU  - Yanaba,Koichi
AU  - Umezawa,Yoshinori
AU  - Sakakihara,Reiko
AU  - Chiba,Miki
AU  - Ito,Toshihiro
AU  - Kikuchi,Sota
AU  - Fukuchi,Osamu
AU  - Asahina,Akihiko
AU  - Saeki,Hidehisa
AU  - Nakagawa,Hidemi
TI  - Infliximab and adalimumab, unlike ustekinumab, increase serum KL-6 levels in Japanese patients with psoriasis
SN  - 1346-8138
PY  - 2016///0824
KW  - Adalimumab
KW  - Antibodies, Monoclonal
KW  - Antibodies, Monoclonal, Humanized
KW  - Humans
KW  - Infliximab
KW  - Psoriasis
KW  - Ustekinumab
N1  - Publication Type: Letter; Comment
UR  - https://doi.org/10.1111/1346-8138.12918
ER  -